| DHAD | mitoxantrone hydrochloride |
|---|
| MIT | Mitoxantrone |
|---|---|
| MITO | Mitoxantrone |
| MITOX | Mitoxantrone |
| MTX | Mitoxantrone |
| MX | Mitoxantrone |
| mitoxantrone | <chemical> An anthracenedione antineoplastic agent. It is particularly effective against advanced breast cancer, acute leukaemia, and malignant lymphoma. It has mild side effects, especially with respect to nausea, vomiting, hair loss, and cardiotoxicity. Pharmacological action: analgesics, antineoplastic agent. Chemical name: 9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)- (12 Dec 1998) |
|---|---|
| mitoxantrone hydrochloride | 1,4-Dihydro-5,8-bis[[2-[2-hydroxyethyl)-amino]ethyl]anthraquinone dihydrochloride;a synthetic anti-neoplastic used intravenously in the initial therapy for acute nonlymphocytic leukaemia in adults. (05 Mar 2000) |
Synonyms : AHP Brand of Mitoxantrone Hydrochloride, ASTA Medica Brand of Mitoxantrone Hydrochloride, Amgen Brand of Mitoxantrone Hydrochloride, Baxter Oncology Brand of Mitoxantrone Hydrochloride, CL-232325, Columbia Brand of Mitoxantrone Hydrochloride, DHAQ, Mitroxone
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|---|---|---|---|
|
산트론주 - 새창
|
한국유나이티드제약 |
A12941851 | Mitoxantrone HCl | 전문의약품 | 급여 | 분업예외의약품 |
|
노반트론주20mg - 새창
|
Wyeth |
E02800051 | Mitoxantrone HCl | 전문의약품 | 급여 | 분업예외의약품 |
|
바이트론주사 - 새창
|
아주약품공업 |
A05605791 | Mitoxantrone HCl | 전문의약품 | 삭제 |
|
노반트론주10mg - 새창
|
Wyeth |
E30540021 | Mitoxantrone HCl | 전문의약품 | 삭제 |
|
미트론주10mg - 새창
|
이연제약 |
A01451241 | Mitoxantrone HCl | 전문의약품 | 급여 |
|
미트론주 - 새창
|
이연제약 |
A01401671 | Mitoxantrone HCl | 전문의약품 | 급여 | 분업예외의약품 |
|
젠파드론주 - 새창
|
제이텍바이오젠 |
W11960311 | Mitoxantrone HCl | 전문의약품 | 급여 |
|
동국염산미톡산트론주사 - 새창
|
동국제약 |
A00701282 | Mitoxantrone HCl | 전문의약품 | 삭제 | 분업예외의약품 |
|
종근당미토산트론주 - 새창
|
종근당 |
A01250281 | Mitoxantrone HCl | 전문의약품 | 삭제 | 분업예외의약품 |
| mitoxantrone hydrochloride |
[USP] a DNA-intercalating agent of the anthracenedione family that causes cross-links and strand breaks and also inhibits type II topoisomerase; used as an antineoplastic agent for the treatment of acute myelogenous leukemia and the palliative treatment of advanced hormone-refractory prostate cancer. It is also used to reduce the frequency and severity of relapses in patients with secondary multiple sclerosis. Administered intravenously.
출처: www.mercksource.com/pp/us/cns/cns_health_library.j...
|
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
